IAMA 6
Alternative Names: IAMA-6Latest Information Update: 05 Feb 2024
At a glance
- Originator IAMA
- Class Antiepileptic drugs; Behavioural disorder therapies; Small molecules
- Mechanism of Action Sodium-potassium-chloride symporter inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Autistic disorder; Epilepsy